Clinical Trials Directory

Trials / Completed

CompletedNCT00943150

PEAK PlasmaBlade™ vs. Traditional Electrosurgery in Abdominoplasty

A Prospective, Randomized, Controlled Two-arm Superiority Study to Evaluate Use of the PEAK PlasmaBlade™ 4.0 in Abdominoplasty

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Medtronic Surgical Technologies · Industry
Sex
All
Age
25 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The objective of this clinical study is to evaluate healing of incisions made with the PEAK PlasmaBlade 4.0 compared to scalpel and traditional electrosurgery (Bovie); to monitor and record key post-operative metrics following abdominoplasty with the PEAK PlasmaBlade 4.0 versus current standard of care (SOC); and to evaluate performance metrics of the PEAK PlasmaBlade 4.0 during abdominoplasty.

Detailed description

Abdominoplasty is a cosmetic surgical procedure performed to correct abdominal elastosis with skin and fat redundancy. During the procedure, a scalpel and traditional electrosurgical device are used to cut away this excess skin and fat from the abdomen and the underlying muscles are tightened together with sutures. The PEAK PlasmaBlade™ uses pulsed radiofrequency (RF) energy to enable precision cutting and coagulating at the point of application, without the thermal damage to surrounding tissues that is normally seen with traditional electrosurgery. The PlasmaBlade has received FDA clearance for use in plastic, general, and ear, nose, and throat (ENT) surgery, and has demonstrated significantly reduced serous drainage in tissue reduction surgeries, like abdominoplasty. A total of twenty (20) human subjects were recruited from the local community against standardized inclusion/exclusion criteria. Once enrolled, each patient underwent placement of three sets of full-thickness comparison incisions in their abdominal skin with a standard scalpel, PlasmaBlade, and traditional electrosurgery at six (6) and three (3) weeks prior to abdominoplasty, and on the day of surgery under general anesthesia. Subjects were then randomized to undergo abdominoplasty with the PlasmaBlade or the SOC (scalpel and traditional electrosurgery). Following abdominoplasty, harvested healed incisions were submitted for histological analysis and burst strength testing and additional data were recorded in the 10 day post-operative period.

Conditions

Interventions

TypeNameDescription
DEVICEPEAK PlasmaBladeThe PEAK PlasmaBlade will be used for the abdominoplasty procedure.
PROCEDUREStandard of Care (SOC)The scalpel and electrocautery will be used for the abdominoplasty procedure.

Timeline

Start date
2008-12-01
Primary completion
2011-06-01
Completion
2011-06-01
First posted
2009-07-22
Last updated
2013-01-01
Results posted
2013-01-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00943150. Inclusion in this directory is not an endorsement.